**Question:** Glycosylated haemoglobin assay is helpful in the monitoring of patients with:

**Core Concept:**
Glycosylated haemoglobin (HbA1c) is a laboratory test that measures the average blood glucose levels over the previous 2-3 months. It is used to diagnose and monitor diabetes mellitus, as well as assess the effectiveness of diabetes treatments.

**Why the Correct Answer is Right:**
The correct answer (D) refers to the most common and relevant use of the HbA1c assay. In diabetes mellitus, high blood glucose levels cause glucose molecules to bind non-enzymatically to the amino groups of the haemoglobin molecules in red blood cells. Over time, these glycated haemoglobin (HbA1c) levels increase, reflecting the average blood glucose levels over the previous 2-3 months. Monitoring HbA1c levels helps in assessing glycaemic control, identifying and managing hyperglycaemia, and evaluating the effects of diabetes treatments.

**Why Each Wrong Option is Incorrect:**
A) is incorrect because it refers to monitoring only after starting insulin therapy, which is a specific scenario and not the broader concept of using HbA1c for diabetes monitoring.
B) is incorrect because it focuses on monitoring only during pregnancy, which is a specific condition and not the broader concept of using HbA1c for diabetes monitoring.
C) is incorrect because it refers to monitoring only in patients with type 1 diabetes, which is a specific type of diabetes and not the broader concept of using HbA1c for diabetes monitoring.

**Correct Answer:** D) Monitoring glycaemic control in patients with diabetes mellitus. This option encompasses the broader concept of using HbA1c for monitoring blood glucose levels and assessing the effectiveness of diabetes treatments.